SITC Resource Library

Course 2: Guidelines and Best Practices on Designing Clinical Trials with Exploratory Surrogate Endpoints and CDX: Computational Science in Immuno-oncology 

05-14-2025 08:50

On May 8, 2025, the Society for Immunotherapy of Cancer (SITC) in partnership with the National Cancer Institute (NCI) held the second computational immuno-oncology webinar of series 5. The recording of the second webinar "Course 2 - Guidelines and Best Practices on Designing Clinical Trials with Exploratory Surrogate Endpoints and CDX: Computational Science in Immuno-oncology" is available below.

Webinar Faculty

  • Academic Presenter: Janice M. Mehnert, MD  NYU Langone Health
  • Industry Presenter: Rui (Sammi) Tang, PhD, MBA Astellas Pharma US, Inc.
  • Moderator: Julie Rytlewski, PhD – Bristol Myers Squibb


Program Information

In partnership with and partial funding by the National Cancer Institute (NCI), the Society for Immunotherapy of Cancer (SITC) is pleased to launch our fifth iteration of the "SITC-NCI Computational Immuno-oncology Webinar Series" throughout April-December 2025. This year's series will focus specifically on advanced methods and clinical utility for biomarker development in IO.

Organized by the SITC Big Data and Data Sharing Committee, these ten free-to-attend digital events will help individual research labs to embrace the computational challenges of analyzing and integrating diverse assay data across the spectrum of immuno-oncology for biomarker development. The goal of this series is to help foster better communication concerning data science technologies and analyses between cancer immunotherapy researchers and clinicians. All webinars in this series will take place live and be made available in their entirety on the SITC ConnectED platform as enduring materials.

Statistics
0 Favorited
30 Views
3 Files
0 Shares
13 Downloads
Attachment(s)
pdf file
Janice M. Mehnert - Slides   3.83 MB   1 version
Uploaded - 05-14-2025
pdf file
Rui (Sammi) Tang - Slides   2.57 MB   1 version
Uploaded - 05-14-2025

Related Entries and Links

No Related Resource entered.